The Phosphatidylinositol 3-Kinase Pathway in Human Malignancies Chapter uri icon

Overview

MeSH Major

  • Fructose
  • Neoplasms
  • Sweetening Agents

abstract

  • © 2016 by John Wiley & Sons, Inc. All rights reserved.Cancer accounts for one-quarter of all deaths in the United States, and alterations in the phosphatidylinositol-3-kinase (PI3K) pathway components are some of the most frequent genomic alterations in human malignancies. The study of the PI3K pathway has translated into improved understanding of tumorigenesis and led to the identification of multiple therapeutic targets. Inhibition of the PI3K pathway across multiple tumor types is already translating into improved patient outcomes in several cancers, and multiple clinical investigations are ongoing. In this chapter, we have reviewed the major components of the canonical PI3K signal transduction cascade and highlighted translational studies investigating inhibition of the PI3K pathway in human malignancies.

publication date

  • October 30, 2015

Research

keywords

  • Book Chapter

Identity

Digital Object Identifier (DOI)

  • 10.1002/9781118468678.ch32

Additional Document Info

start page

  • 315

end page

  • 324